Increased levels of transforming growth factor β1 and basic fibroblast growth factor in patients on CAPD: A study during non-infected steady state and peritonitis

Inflammation

Volumn 23, Issue 2, 1999, Pages 131-139

  Mlambo, Nokwanda C ^a   Hylander, Britta ^a   Brauner, Annelie ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DIALYSATE; EFFLUENT; FEMALE; FIBROSIS; FOLLOW UP; HUMAN; MALE; PERITONEUM; PERITONITIS; TREATMENT FAILURE; ULTRAFILTRATION;

EID: 0032948478     PISSN: 03603997     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020288911885     Document Type: Article

References (24)

1. 1. Wahl, S. M. 1992. Transforming growth factor beta (TGF-β) in inflammation: a cause and a cure. J. Clin. Immunol. 12:61-74.
2. 2. Ignotz, R. A. and J. Massagué. 1986. Transforming growth factor β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J. Biol. Chem. 261:4337-4345.
3. 3. Assoian, R. K., B. E. Fleurdelys, H. C. Stevenson, P. J. Miller, D. K. Madtes, E. W. Raines, R. Ross, and M. B. Sporn. 1987. Expression and secretion of type β transforming growth factor by activated human macrophages. Proc. Natl. Acad. Sci. U.S.A. 84:6020-6024.
4. 4. Offner, F. A., H. Feichtinger, S. Stadlmann, P. Obrist, C. Marth, P. Klingler, B. Grace, M. Schmahl, and C. Knabbe. 1996. Transforming growth factor β synthesis by human peritoneal mesothelial cells. Induction by interleukin-1. Am. J. Pathol. 148:1679-1688.
5. 5. Border, W. A., and N. A. Noble. 1993. Cytokines in kidney disease: the role of transforming growth factor-β. Am. J. Kidney Dis. 22:105-113.
6. 6. Van Laethem, J. L., P. Robberecht, A. Résibois, and J. Devière. 1996. Transforming growth factor β promotes development of fibrosis after repeated courses of acute pancreatitis in mice. Gastroenterology 110:576-582.
7. 7. Nakamoto, M. 1996. Pathogenesis of peritoneal fibrosis and peritoneal small vessel changes. Perit. Dial. Int. 16:S39-41.
8. 8. Honda, K., K. Nitta, S. Horita, W. Yumura, and H. Nihei. 1996. Morphological changes in the peritoneal vasculature of patients on CAPD with ultrafiltration failure. Nephron 72:171-176.
9. 9. Burgess, W. H., and T. Maciag. 1989. The heparin-binding (fibroblast) growth factor family of proteins. Annu. Rev. Biochem. 58:575-600.
10. 10. Parish, M. A., E. A. Grossi, G. Baumann, T. Asai, D. B. Rifkin, S. B. Colvin, and A. C. Galloway. 1995. Effects of a single administration of fibroblast growth factor on vascular wall reaction to injury. Ann. Thorac. Surg. 59:948-954.
11. 11. D'Andrea, A., X. Ma, M. Aste-Amezaga, C. Paganin, and G. Trinchieri. 1995. Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: priming for IL-12 and tumor necrosis factor α production. J. Exp. Med. 181:537-546.
12. 12. Deleuran, B., L. Iversen, M. Deleuran, M. Yssel, K. Kragballe, K. Stengaard-Pedersen, and K. Thestrup-Pedersen. 1995. Interleukin 13 suppresses cytokine production and stimulates the production of 15-HETE in PBMC. CYTOKINE 7:319-324.
13. 13. D'Andrea, A., M. Rengaraju, N. M. Valiante, J. Chehimi, M. Kubin, M. Aste, S. H. Chan, M. Kobyashi, D. Young, E. Nickbarg, R. Chizzonite, S. F. Wolf, and G. Trinchieri. 1992. Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J. Exp. Med. 176:1387-1398.
14. 14. Manetti, R., P. Parronchi, M. G. Giudizi, M.-P. Piccinni, E. Maggi, G. Trinchieri, and S. Romagnani. 1993. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type I (Th1)-specific immune responses and inhibits the development of IL-4 producing Th cells. J. Exp. Med. 177:1199-1204.
15. 15. Mcgregor, S. J., N. Topley, A. Jörres, B. J. Speekenbrink, A. Gordon, G. M. Gah, B. J. R. Junor, J. D. Briggs, and J. H. Brock. 1996. Longitudinal evaluation of peritoneal macrophage function and activation during CAPD: Maturity, cytokine synthesis and arachidonic acid metabolism. Kidney Int. 49:525-533.
16. 16. Brauner, A., Y. Lu, G. Halldén, B. Hylander, and J. Lundahl. 1998. Difference in the blood monocyte phenotype between uremic patients and healthy controls; its relation to monocyle differentiation into macrophages in the peritoneal cavity. Inflammation 22:55-66.
17. 17. Rocco, M. V., Y. Chen, S. Goldfarb, F. N. Ziyadeh. 1992. Elevated glucose stimulates TGF-beta gene expression and bioactivity in proximal tubule. Kidney Int. 41:107-114.
18. 18. Wang, T., Y. G. Ghen, R. G. Ye, W. Y. Mai, Z. H. Zhen, and H. Q. Li. 1995. Enhanced expression of TGF-β1 by peritoneal macrophages in CAPD patients. Adv. Perit. Dial. 11:11-14.
19. 19. Lin, C. Y., W. P. Chen, L. W. Fu, L. Y. Yang, and T. P. Huang. 1997. Persistent transforming growth factor β1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence. Adv. Perit. Dial. 13:64-71.
20. 20. Perfumo, F., P. Altieri, M. L. Degl'Innocenti, G. M. Ghiggeri, G. Caridi, A. Trivelli, and R. Gusmano. 1996. Effects of peritoneal effluents on mesothelial cells in culture: cell proliferation and extracellular matrix regulation. Nephrol. Dial. Transplant. 11:1803-1809.
21. 21. Pepper, M. S., J. D. Vassalli, L. Orci, and R. Montesano. 1993. Biphasic effect of transforming growth factor-β1 on in vitro angiogenesis. Exp. Cell. Res. 204:356-363.
22. + T cells. Proc. Natl. Acad. Sci., U.S.A. 91:2890-2894.
23. 23. Vlodavsky, I., P. Bashkin, R. Ishai-Michaeli, T. Chajek-Shaul, R. Bar-Shavit, A. Haimovitz-Friedman, M. Klagsbrun, and Z. Fuks. 1991. Sequestration and release of basic fibroblast growth factor. Ann. N.Y. Acad. Sci. 638:207-220.
24. 24. Nicolleti, F., G. Mancuso, V. Cusumano, R. Di Marco, P. Zaccone, K. Bendtzen, and G. Teti. 1997. Prevention of endotoxin-induced lethality in neonatal mice by interleukin-13. Eur. J. Immunol. 27:1580-1583.